...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis, and biological evaluation of (2E)-(2-oxo-1, 2-dihydro-3H-indol-3-ylidene)acetate derivatives as anti-proliferative agents through ROS-induced cell apoptosis
【24h】

Design, synthesis, and biological evaluation of (2E)-(2-oxo-1, 2-dihydro-3H-indol-3-ylidene)acetate derivatives as anti-proliferative agents through ROS-induced cell apoptosis

机译:(2E) - (2-氧代-1,2-二氢-3H-吲哚-3-吲哚-3-甘酮)乙酸酯衍生物通过ROS诱导细胞凋亡的抗增殖药物的设计,合成和生物学评价

获取原文
获取原文并翻译 | 示例

摘要

A novel class of (2E)-(2-oxo-1, 2-dihydro-3H-indol-3-ylidene)acetate derivatives were designed and synthesized as potent anti-proliferative agents. Most of these compounds showed potent anti proliferative activity against some tumor cell lines, including SK-BR-3, MDA-MB-231, HCT-116, SW480, Ovcar-3, HL-60, Saos-2 and HepG2. Compounds 8c and 11h were identified as the most potent ones, while HL-60, HCT116 and MDA-MB-231 were the most sensitive cell lines. Mechanistic study revealed that compound 8c enhanced reactive oxygen species level by inhibiting TrxR and then induced apoptosis by activating apoptosis proteins, bax and cleaved-caspase 3 in HCT116 cells. Preliminary SAR analysis indicated that modifications of the double bond and ester group made great effects on the anti proliferative activity. Our findings suggested that it was worth further studies on the antitumor potency of (2E)-(2-oxo-1, 2-dihydro-3H-indol-3-ylidene)acetates. (C) 2016 Elsevier Masson SAS. All rights reserved.
机译:设计并合成了一种新的(2E) - (2-氧代-1,2-二氢-3-吲哚-3-甘酮)乙酸酯衍生物作为有效的抗增殖剂。 这些化合物中的大多数表现出对某些肿瘤细胞系的有效的抗增殖活性,包括SK-BR-3,MDA-MB-231,HCT-116,SW480,OVCAR-3,HL-60,SAOS-2和HepG2。 将化合物8C和11H鉴定为最有效的,而HL-60,HCT116和MDA-MB-231是最敏感的细胞系。 机械研究表明,通过在HCT116细胞中激活细胞凋亡蛋白质,Bax和切割的水疗酶3,通过抑制TRXR和诱导细胞凋亡,化合物8C增强活性氧物质水平。 初步SAR分析表明双键和酯类的修饰对抗增殖活性产生了很大的影响。 我们的研究结果表明,对(2E) - (2-氧代-1,2-二氢-3H-吲哚-3-吲哚-3-甘醇-3-甘蔗)的抗肿瘤效力是值得的。 (c)2016年Elsevier Masson SAS。 版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号